Clinical study

Bacteriophage Therapy for Orthopedic Implant-Associated Infections

Status	Not yet recruiting
Type	Trial
Countries	China
Conditions studied	Orthopedic; Implant Infection
Study years	2026 (estimated)–2030 (estimated)
Entry review	2026-10-03

Participation

Check the study record or contact the study team for current recruitment and eligibility.

Study eligibility

Inclusion Criteria: * Known allergy or hypersensitivity to bacteriophages or any components of the bacteriophage preparation; * Pregnant or breastfeeding women; * Participation in another interventional clinical trial within the study period; * Lack of feasible routes of administration other than intravenous injection; * Patients deemed unsuitable for participation in this study by the investigator; * Inability or unwillingness of the subject to comply with study procedures. Exclusion Criteria: * Withdrawal of informed consent by the participant at any time during the study; * Occurrence of serious adverse events related to bacteriophage therapy that, in the investigator's judgment, necessitate discontinuation of treatment.

Study description

A Prospective, Single-Center, Single-Arm Clinical Study with a Pre-Post Self-Controlled Design Evaluating the Efficacy and Safety of Bacteriophage Therapy for Refractory Orthopedic Implant-Associated Infections

Study registrations

ClinicalTrials.gov	NCT07533292

Recorded study locations (1)

Locations listed in the study record; this does not confirm current recruitment or treatment outside the study. A site label may be older than the overall study status.